What dosage range is associated with Hematologic Syndrome?

Hematologic Syndrome is characterized by significant changes in blood cell counts due to radiation exposure. The dosage range associated with this syndrome typically occurs between 200 to 1000 rad. Within this range, the bone marrow, which is crucial for the production of blood cells, is affected, leading to symptoms such as anemia, increased susceptibility to infections, and bleeding disorders. These manifestations arise because radiation impairs the bone marrow's ability to produce red blood cells, white blood cells, and platelets.

The dosages outside this range, while causing other syndromes or health effects, do not specifically pertain to the hematologic impact seen at lower levels of radiation exposure. Understanding these thresholds is crucial for recognizing and managing radiation-induced health effects effectively.